Matthew J Atherton (Matthew Atherton)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 20

Top Topics

Induced Pluripotent Stem Cells

Platelet Rich Plasma

Diffuse Large B Cell Lymphoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Veterinary and comparative oncology

Journal of veterinary internal medicine

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Antonia Rotolo, Matthew J Atherton
Applications and Opportunities for Immune Cell CAR Engineering in Comparative Oncology. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Antonia Rotolo, Matthew J Atherton
Applications and opportunities for immune cell CAR engineering in comparative oncology. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Antonia Rotolo, Matthew J Atherton
Applications and Opportunities for Immune Cell CAR Engineering in Comparative Oncology. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Antonia Rotolo, Matthew J Atherton
Applications and opportunities for immune cell CAR engineering in comparative oncology. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Dillon S Didehvar, Matthew R Lanza, Matthew J Atherton, Jennifer A Lenz
Malignant transformation and subsequent leptomeningeal carcinomatosis of a gastric polyp in a dog. Journal of veterinary internal medicine 38 (3) (2024)
Antonia Rotolo, Matthew J Atherton
Applications and Opportunities for Immune Cell CAR Engineering in Comparative Oncology. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Dillon S Didehvar, Matthew R Lanza, Matthew J Atherton, Jennifer A Lenz
Malignant transformation and subsequent leptomeningeal carcinomatosis of a gastric polyp in a dog. Journal of veterinary internal medicine 38 (3) (2024)
Dillon S Didehvar, Matthew R Lanza, Matthew J Atherton, Jennifer A Lenz
Malignant transformation and subsequent leptomeningeal carcinomatosis of a gastric polyp in a dog. Journal of veterinary internal medicine (2024)
Antonia Rotolo, Matthew J Atherton
Applications and opportunities for immune cell CAR engineering in comparative oncology. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Dillon S Didehvar, Matthew R Lanza, Matthew J Atherton, Jennifer A Lenz
Malignant transformation and subsequent leptomeningeal carcinomatosis of a gastric polyp in a dog. Journal of veterinary internal medicine 38 (3) (2024)
Antonia Rotolo, Matthew J Atherton
Applications and Opportunities for Immune Cell CAR Engineering in Comparative Oncology. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Kelley Zimmerman, Koranda A Walsh, Jonathan T Ferrari, Nicholas S Keuler, Matthew J Atherton, Jennifer A Lenz
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma. Veterinary and comparative oncology (2023)
Jennifer A Lenz, Sarah E Benjamin, Koranda A Walsh, Nicholas S Keuler, Matthew J Atherton
Calculation of dose intensity & comparison of published methods using a cohort of canine T-cell lymphoma patients undergoing CHOP-based chemotherapy. Veterinary and comparative oncology (2023)
Matthew J Atherton, Nicola J Mason
Bite-size introduction to canine hematologic malignancies. Blood advances 6 (13) (2022)
Allison Gedney, Pascale Salah, Jennifer A Mahoney, Erika Krick, Reenie Martins, Heather Scavello, Jennifer A Lenz, Matthew J Atherton
Evaluation of the anti-tumour activity of Coriolus versicolor polysaccharopeptide (I'm-Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma. Veterinary and comparative oncology 20 (3) (2022)
Zhen Lu, Jinyun Chen, Pengfei Yu, Matthew J Atherton, Jun Gui, Vivek S Tomar, Justin D Middleton, Neil T Sullivan, Sunil Singhal, Subin S George, Ashley G Woolfork, Aalim M Weiljie, Tsonwin Hai, Evgeniy B Eruslanov, Serge Y Fuchs
Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer. Nature communications 13 (1) (2022)
Hongru Zhang, Pengfei Yu, Vivek S Tomar, Xiangjie Chen, Matthew J Atherton, Zhen Lu, Hong-Guang Zhang, Shifeng Li, Angelica Ortiz, Jun Gui, N Adrian Leu, Fangxue Yan, Andres Blanco, Mirella L Meyer-Ficca, Ralph G Meyer, Daniel P Beiting, Jinyang Li, Selene Nunez-Cruz, Roddy S O'Connor, Lexus R Johnson, Andy J Minn, Subin S George, Constantinos Koumenis, J Alan Diehl, Michael C Milone, Hui Zheng, Serge Y Fuchs
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors. Nature cancer 3 (7) (2022)
Sarah E Benjamin, Karin U Sorenmo, Erika L Krick, Pascale Salah, Koranda A Walsh, Nicole M Weinstein, Nicholas S Keuler, Anne C Avery, Matthew J Atherton, Jennifer A Lenz
Response-based modification of CHOP chemotherapy for canine B-cell lymphoma. Veterinary and comparative oncology 19 (3) (2021)
Amy K LeBlanc, Matthew J Atherton, R Timothy Bentley, C Elizabeth Boudreau, Jenna H Burton, Kaitlin M Curran, Steven Dow, Michelle A Giuffrida, Heidi B Kellihan, Nicola J Mason, Michelle L Oblak, Laura Elizabeth Selmic, Kimberly A Selting, Ameet Singh, Sonja Tjostheim, David M Vail, Kristen M Weishaar, Erika P Berger, John H Rossmeisl, Christina Mazcko
Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and cats. Veterinary and comparative oncology 19 (2) (2021)
Jennifer A Lenz, Charles-Antoine Assenmacher, Victoria Costa, Katie Louka, Suzanne Rau, Nicholas S Keuler, Paul J Zhang, Robert G Maki, Amy C Durham, Enrico Radaelli, Matthew J Atherton
Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma. Cancer immunology, immunotherapy : CII (2021)